| abstract |
The present invention relates to the use of nucleotide analogs, defined as molecules capable of being taken as a substrate for the reverse transcription reaction and of allowing the addition of at least one additional nucleotide to the polynucleotide chain. summary course to affect and / or take control of the fidelity and processivity of reverse transcription. It also relates to the pharmaceutical composition containing these nucleotide analogs. |